RE:Pfizer reshuffles executive with focus on I/O Pfizer's acquisition of ONCY at this time in pelareorep's advanced clinical development stage would give both Andy Schmeltz, Pfizer's new VP Commercial Strategy and Innovation, and Sunetet Varma, Pfizer's new Global Oncology Chief and US President, and early win in their new roles.